R&D News | pharmaphorum

News

US experts trial AZ's long-acting COVID-19 antibody combinat...

An international trial led by US experts is to begin testing AstraZeneca’s long-acting antibody combination therapy to treat COVID-19.

News

China approves Sinovac's coronavirus vaccine

China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public.

News

UK targets COVID-19 variants with new order for CureVac jab

The UK has agreed a 50 million-dose order for a COVID-19 vaccine with German biotech CureVac to support development of a shot that specifically targets emerging variants of the virus.

Views & Analysis

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

Dilemma for Biden as Woodcock’s audition for FDA chief stumb...

The change of administration in the US has also seen a new leader at the FDA, with Dr Janet Woodcock appointed as interim commissioner by president Joe Biden’s new team.

News

The rise and rise of digital health investment

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a l

News

GSK/CureVac target new COVID variants with next-gen shot

GlaxoSmithKline and CureVac are to begin developing a next generation vaccine targeting emerging variants of the coronavirus – although it is unlikely to be ready until at least next year.<

US experts trial AZ's long-acting COVID-19 antibody combinat...

China approves Sinovac's coronavirus vaccine

UK targets COVID-19 variants with new order for CureVac jab

Dilemma for Biden as Woodcock’s audition for FDA chief stumb...

UK biotech investment at record levels amid COVID-19

GSK/CureVac target new COVID variants with next-gen shot

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks